October's top stories: Clinical trial to test aspirin, treatment for liposarcoma
FDA grants breakthrough status for Pfizer's leukaemia drug inotuzumab ozogamicin, Alkermes's Aristada gets FDA approval to treat schizophrenia, Domainex and Imperial to discover new therapies for myocardial infarction. Pharmaceutical-technology.com w…
Source: Pharmaceutical Technology - Category: Pharmaceuticals Source Type: news
More News: Aspirin | Clinical Trials | Grants | Heart Attack | Leukemia | Liposarcoma | Pfizer | Pharmaceuticals | Schizophrenia